LDLR
Familial Hypercholesterolemia: LDLR Deletion/Duplication MLPA
Familial Hypercholesterolemia: LDLR Deletion/Duplication MLPA
LDLR deletion/duplication MLPA is a molecular test used to identify copy number variants in the gene associated with familial hypercholesterolemia. This test can also confirm a diagnosis and identify disease-causing variants within a family to facilitate carrier screening.
Familial hypercholesterolemia
Clinical Information
Familial hypercholesterolemia has an estimated prevalence of 1 in 200-250 individuals, and copy number variants in LDLR account for up to 10% of cases. This condition is associated with significant elevations in low-density lipoprotein (LDL) cholesterol. In addition, total cholesterol is typically increased (usually greater than 300 mg/dL in untreated individuals) with normal to slight elevations in triglycerides. Familial hypercholesterolemia is associated with increased risk of premature cardiovascular disease, specifically atherosclerosis, and symptoms include angina, heart attack, and rarely stroke. Other findings include a hazy ring along the outer rim of the iris known as corneal arcus and xanthomas, particularly of the hands and Achilles tendon.
Technical Information
Specimen Requirements
Transport Instructions
Associated Tests
Connect With Our Experts
Call 1-800-473-9411 to speak with our team of laboratory genetic counselors for questions or additional information.
Robin Fletcher, MS, CGC
Falecia Thomas, MS, CGC
Alex Finley, MS, CGC
